News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
250,919 Results
Type
Article (18213)
Company Profile (39)
Press Release (232667)
Section
Business (72553)
Career Advice (391)
Deals (12756)
Drug Delivery (32)
Drug Development (32156)
Employer Resources (44)
FDA (5722)
Job Trends (5400)
News (121994)
Policy (9344)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Pharm Country Standard (1)
2026 Genetown Elite (1)
Academia (1879)
Adcomms (14)
Allergies (25)
Alliances (21005)
ALS (29)
Alzheimer's disease (684)
Antibody-drug conjugate (ADC) (40)
Approvals (5740)
Artificial intelligence (98)
Autoimmune disease (6)
Automation (5)
Bankruptcy (54)
Best Places to Work (4756)
BIOSECURE Act (16)
Biosimilars (32)
Biotechnology (27)
Bladder cancer (32)
Brain cancer (11)
Breast cancer (106)
Cancer (993)
Cardiovascular disease (64)
Career advice (356)
Career pathing (8)
CAR-T (73)
Cell therapy (195)
Cervical cancer (11)
Clinical research (25190)
Collaboration (367)
Compensation (46)
Complete response letters (3)
COVID-19 (1444)
CRISPR (23)
C-suite (83)
Cystic fibrosis (41)
Data (916)
Denatured (3)
Depression (12)
Diabetes (72)
Diagnostics (2624)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (39)
Drug pricing (30)
Drug shortages (7)
Duchenne muscular dystrophy (42)
Earnings (24067)
Editorial (9)
Employer branding (7)
Employer resources (38)
Events (34553)
Executive appointments (246)
FDA (6155)
Featured Employer (14)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (375)
Gene editing (47)
Generative AI (5)
Gene therapy (147)
GLP-1 (222)
Government (1610)
Guidances (18)
Healthcare (7856)
Huntington's disease (9)
IgA nephropathy (9)
Immunology and inflammation (39)
Indications (13)
Infectious disease (1512)
Inflammatory bowel disease (49)
Inflation Reduction Act (3)
Influenza (28)
Intellectual property (38)
Interviews (54)
IPO (6315)
IRA (15)
Job creations (852)
Job search strategy (317)
Kidney cancer (8)
Labor market (8)
Layoffs (87)
Legal (1635)
Liver cancer (33)
Lung cancer (156)
Lymphoma (65)
Machine learning (1)
Management (12)
Manufacturing (97)
MASH (24)
Medical device (4437)
Medtech (4438)
Mergers & acquisitions (6721)
Metabolic disorders (185)
Multiple sclerosis (25)
NASH (10)
Neurodegenerative disease (27)
Neuropsychiatric disorders (8)
Neuroscience (865)
NextGen: Class of 2025 (2480)
Non-profit (2205)
Northern California (983)
Now hiring (5)
Obesity (91)
Opinion (97)
Ovarian cancer (51)
Pain (30)
Pancreatic cancer (38)
Parkinson's disease (46)
Partnered (8)
Patents (78)
Patient recruitment (40)
Peanut (14)
People (23500)
Pharmaceutical (16)
Pharmacy benefit managers (1)
Phase I (8697)
Phase II (11290)
Phase III (7861)
Pipeline (471)
Podcasts (6)
Policy (49)
Postmarket research (797)
Preclinical (3925)
Press Release (28)
Prostate cancer (36)
Psychedelics (15)
Radiopharmaceuticals (109)
Rare diseases (132)
Real estate (1887)
Recruiting (17)
Regulatory (6809)
Reports (12)
Research institute (1983)
Resumes & cover letters (39)
Rett syndrome (1)
RNA editing (2)
RSV (11)
Schizophrenia (22)
Series A (66)
Series B (39)
Sickle cell disease (29)
Southern California (792)
Spinal muscular atrophy (83)
Sponsored (11)
Startups (1590)
Stomach cancer (7)
Supply chain (20)
The Weekly (3)
United States (8366)
Vaccines (332)
Venture capitalists (13)
Webinars (5)
Weight loss (52)
Women's health (10)
Worklife (5)
Date
Today (32)
Last 7 days (267)
Last 30 days (1017)
Last 365 days (13403)
2025 (3101)
2024 (14019)
2023 (16219)
2022 (21055)
2021 (22720)
2020 (21682)
2019 (18033)
2018 (13583)
2017 (12822)
2016 (12141)
2015 (14432)
2014 (10471)
2013 (8650)
2012 (8891)
2011 (9423)
2010 (7932)
Location
Africa (273)
Alabama (34)
Alaska (4)
Arizona (70)
Arkansas (5)
Asia (15124)
Australia (2977)
California (2148)
Canada (563)
China (162)
Colorado (83)
Connecticut (111)
Delaware (48)
Europe (33763)
Florida (366)
Georgia (70)
Idaho (14)
Illinois (180)
India (8)
Indiana (87)
Iowa (1)
Japan (66)
Kansas (22)
Kentucky (18)
Louisiana (2)
Maine (11)
Maryland (281)
Massachusetts (1635)
Michigan (50)
Minnesota (93)
Missouri (35)
Montana (15)
Nebraska (7)
Nevada (10)
New Hampshire (18)
New Jersey (690)
New Mexico (10)
New York (695)
North Carolina (343)
North Dakota (4)
Northern California (983)
Ohio (73)
Oklahoma (8)
Oregon (13)
Pennsylvania (492)
Rhode Island (10)
South America (456)
South Carolina (6)
Southern California (792)
Tennessee (49)
Texas (323)
Utah (58)
Virginia (57)
Washington D.C. (39)
Washington State (300)
West Virginia (2)
Wisconsin (16)
250,919 Results for "broad institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery
March 3, 2025
·
5 min read
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard
February 19, 2025
·
3 min read
Press Releases
Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants
March 26, 2025
·
11 min read
Press Releases
Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection
March 27, 2025
·
4 min read
Press Releases
Bioz Badges Highlight the Broad Applications of Chondrex Products
January 14, 2025
·
3 min read
Business
Bayer and Broad Institute extend cancer therapy research collaboration
Bayer and the Broad Institute of MIT and Harvard have renewed their research alliance, adding five years to a 10-year collaboration that has already yielded three clinical oncology candidates.
November 2, 2023
·
3 min read
Press Releases
Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
March 20, 2025
·
7 min read
Press Releases
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
March 19, 2025
·
10 min read
Press Releases
Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
March 28, 2025
·
13 min read
Approvals
GSK Wins Broad Label Expansion for Jemperli in First-Line Endometrial Cancer
In pursuit of Merck’s blockbuster Keytruda, GSK’s Jemperli scored its own broad FDA label expansion, allowing its use in first-line endometrial cancer regardless of biomarker status.
August 2, 2024
·
2 min read
·
Tristan Manalac
1 of 25,092
Next
